Anti-Obesity Prescription Drugs Market
1 Study Coverage
1.1 Anti-Obesity Prescription Drugs Product Introduction
1.2 Global Anti-Obesity Prescription Drugs Outlook 2017 VS 2022 VS 2028
1.2.1 Global Anti-Obesity Prescription Drugs Sales in US$ Million for the Year 2017-2028
1.2.2 Global Anti-Obesity Prescription Drugs Sales in Volume for the Year 2017-2028
1.3 United States Anti-Obesity Prescription Drugs Outlook 2017 VS 2022 VS 2028
1.3.1 United States Anti-Obesity Prescription Drugs Sales in US$ Million for the Year 2017-2028
1.3.2 United States Anti-Obesity Prescription Drugs Sales in Volume for the Year 2017-2028
1.4 Anti-Obesity Prescription Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Anti-Obesity Prescription Drugs in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Anti-Obesity Prescription Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Anti-Obesity Prescription Drugs Market Dynamics
1.5.1 Anti-Obesity Prescription Drugs Industry Trends
1.5.2 Anti-Obesity Prescription Drugs Market Drivers
1.5.3 Anti-Obesity Prescription Drugs Market Challenges
1.5.4 Anti-Obesity Prescription Drugs Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Anti-Obesity Prescription Drugs Market Segment by Type
2.1.1 Pediatric
2.1.2 Adult
2.2 Global Anti-Obesity Prescription Drugs Market Size by Type
2.2.1 Global Anti-Obesity Prescription Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Anti-Obesity Prescription Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Anti-Obesity Prescription Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Anti-Obesity Prescription Drugs Market Size by Type
2.3.1 United States Anti-Obesity Prescription Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Anti-Obesity Prescription Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Anti-Obesity Prescription Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Anti-Obesity Prescription Drugs Market Segment by Application
3.1.1 Hospitals Pharmacies
3.1.2 Retail Pharmacies
3.1.3 E-commerce
3.2 Global Anti-Obesity Prescription Drugs Market Size by Application
3.2.1 Global Anti-Obesity Prescription Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Anti-Obesity Prescription Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Anti-Obesity Prescription Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Anti-Obesity Prescription Drugs Market Size by Application
3.3.1 United States Anti-Obesity Prescription Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Anti-Obesity Prescription Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Anti-Obesity Prescription Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Anti-Obesity Prescription Drugs Competitor Landscape by Company
4.1 Global Anti-Obesity Prescription Drugs Market Size by Company
4.1.1 Top Global Anti-Obesity Prescription Drugs Manufacturers Ranked by Revenue (2021)
4.1.2 Global Anti-Obesity Prescription Drugs Revenue by Manufacturer (2017-2022)
4.1.3 Global Anti-Obesity Prescription Drugs Sales by Manufacturer (2017-2022)
4.1.4 Global Anti-Obesity Prescription Drugs Price by Manufacturer (2017-2022)
4.2 Global Anti-Obesity Prescription Drugs Concentration Ratio (CR)
4.2.1 Anti-Obesity Prescription Drugs Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Anti-Obesity Prescription Drugs in 2021
4.2.3 Global Anti-Obesity Prescription Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Anti-Obesity Prescription Drugs Manufacturing Base Distribution, Product Type
4.3.1 Global Anti-Obesity Prescription Drugs Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Anti-Obesity Prescription Drugs Product Type
4.3.3 Date of International Manufacturers Enter into Anti-Obesity Prescription Drugs Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Anti-Obesity Prescription Drugs Market Size by Company
4.5.1 Top Anti-Obesity Prescription Drugs Players in United States, Ranked by Revenue (2021)
4.5.2 United States Anti-Obesity Prescription Drugs Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Anti-Obesity Prescription Drugs Sales by Players (2020, 2021 & 2022)
5 Global Anti-Obesity Prescription Drugs Market Size by Region
5.1 Global Anti-Obesity Prescription Drugs Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Anti-Obesity Prescription Drugs Market Size in Volume by Region (2017-2028)
5.2.1 Global Anti-Obesity Prescription Drugs Sales in Volume by Region: 2017-2022
5.2.2 Global Anti-Obesity Prescription Drugs Sales in Volume Forecast by Region (2023-2028)
5.3 Global Anti-Obesity Prescription Drugs Market Size in Value by Region (2017-2028)
5.3.1 Global Anti-Obesity Prescription Drugs Sales in Value by Region: 2017-2022
5.3.2 Global Anti-Obesity Prescription Drugs Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Anti-Obesity Prescription Drugs Market Size YoY Growth 2017-2028
6.1.2 North America Anti-Obesity Prescription Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Anti-Obesity Prescription Drugs Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Anti-Obesity Prescription Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Anti-Obesity Prescription Drugs Market Size YoY Growth 2017-2028
6.3.2 Europe Anti-Obesity Prescription Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Anti-Obesity Prescription Drugs Market Size YoY Growth 2017-2028
6.4.2 Latin America Anti-Obesity Prescription Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Anti-Obesity Prescription Drugs Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Anti-Obesity Prescription Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 F Hoffmann La Roche Ltd
7.1.1 F Hoffmann La Roche Ltd Corporation Information
7.1.2 F Hoffmann La Roche Ltd Description and Business Overview
7.1.3 F Hoffmann La Roche Ltd Anti-Obesity Prescription Drugs Sales, Revenue and Gross Margin (2017-2022)
7.1.4 F Hoffmann La Roche Ltd Anti-Obesity Prescription Drugs Products Offered
7.1.5 F Hoffmann La Roche Ltd Recent Development
7.2 Orexigen Therapeutics
7.2.1 Orexigen Therapeutics Corporation Information
7.2.2 Orexigen Therapeutics Description and Business Overview
7.2.3 Orexigen Therapeutics Anti-Obesity Prescription Drugs Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Orexigen Therapeutics Anti-Obesity Prescription Drugs Products Offered
7.2.5 Orexigen Therapeutics Recent Development
7.3 Novo Nordisk A/s
7.3.1 Novo Nordisk A/s Corporation Information
7.3.2 Novo Nordisk A/s Description and Business Overview
7.3.3 Novo Nordisk A/s Anti-Obesity Prescription Drugs Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Novo Nordisk A/s Anti-Obesity Prescription Drugs Products Offered
7.3.5 Novo Nordisk A/s Recent Development
7.4 Arena Pharmaceuticals
7.4.1 Arena Pharmaceuticals Corporation Information
7.4.2 Arena Pharmaceuticals Description and Business Overview
7.4.3 Arena Pharmaceuticals Anti-Obesity Prescription Drugs Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Arena Pharmaceuticals Anti-Obesity Prescription Drugs Products Offered
7.4.5 Arena Pharmaceuticals Recent Development
7.5 Glaxosmithkline
7.5.1 Glaxosmithkline Corporation Information
7.5.2 Glaxosmithkline Description and Business Overview
7.5.3 Glaxosmithkline Anti-Obesity Prescription Drugs Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Glaxosmithkline Anti-Obesity Prescription Drugs Products Offered
7.5.5 Glaxosmithkline Recent Development
7.6 Vivus
7.6.1 Vivus Corporation Information
7.6.2 Vivus Description and Business Overview
7.6.3 Vivus Anti-Obesity Prescription Drugs Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Vivus Anti-Obesity Prescription Drugs Products Offered
7.6.5 Vivus Recent Development
7.7 Boehringer Ingelheim
7.7.1 Boehringer Ingelheim Corporation Information
7.7.2 Boehringer Ingelheim Description and Business Overview
7.7.3 Boehringer Ingelheim Anti-Obesity Prescription Drugs Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Boehringer Ingelheim Anti-Obesity Prescription Drugs Products Offered
7.7.5 Boehringer Ingelheim Recent Development
7.8 Alizyme
7.8.1 Alizyme Corporation Information
7.8.2 Alizyme Description and Business Overview
7.8.3 Alizyme Anti-Obesity Prescription Drugs Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Alizyme Anti-Obesity Prescription Drugs Products Offered
7.8.5 Alizyme Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Anti-Obesity Prescription Drugs Industry Chain Analysis
8.2 Anti-Obesity Prescription Drugs Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Anti-Obesity Prescription Drugs Distributors
8.3 Anti-Obesity Prescription Drugs Production Mode & Process
8.4 Anti-Obesity Prescription Drugs Sales and Marketing
8.4.1 Anti-Obesity Prescription Drugs Sales Channels
8.4.2 Anti-Obesity Prescription Drugs Distributors
8.5 Anti-Obesity Prescription Drugs Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Anti-Obesity Prescription Drugs CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Anti-Obesity Prescription Drugs Market Trends
Table 3. Anti-Obesity Prescription Drugs Market Drivers
Table 4. Anti-Obesity Prescription Drugs Market Challenges
Table 5. Anti-Obesity Prescription Drugs Market Restraints
Table 6. Global Anti-Obesity Prescription Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Anti-Obesity Prescription Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Anti-Obesity Prescription Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Anti-Obesity Prescription Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Anti-Obesity Prescription Drugs Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Anti-Obesity Prescription Drugs Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Anti-Obesity Prescription Drugs Revenue Share by Manufacturer, 2017-2022
Table 13. Global Anti-Obesity Prescription Drugs Sales by Manufacturer, (K Units), 2017-2022
Table 14. Global Anti-Obesity Prescription Drugs Sales Share by Manufacturer, 2017-2022
Table 15. Global Anti-Obesity Prescription Drugs Price by Manufacturer (2017-2022) & (US$/Unit)
Table 16. Global Anti-Obesity Prescription Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Anti-Obesity Prescription Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Obesity Prescription Drugs as of 2021)
Table 18. Top Players of Anti-Obesity Prescription Drugs in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Anti-Obesity Prescription Drugs Product Type
Table 20. Date of International Manufacturers Enter into Anti-Obesity Prescription Drugs Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Anti-Obesity Prescription Drugs Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Anti-Obesity Prescription Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Anti-Obesity Prescription Drugs Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Anti-Obesity Prescription Drugs Sales by Players, (K Units), 2020, 2021 & 2022
Table 26. United States Anti-Obesity Prescription Drugs Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Anti-Obesity Prescription Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Anti-Obesity Prescription Drugs Sales in Volume by Region (2017-2022) & (K Units)
Table 29. Global Anti-Obesity Prescription Drugs Sales in Volume Forecast by Region (2023-2028) & (K Units)
Table 30. Global Anti-Obesity Prescription Drugs Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Anti-Obesity Prescription Drugs Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Anti-Obesity Prescription Drugs Sales in Volume by Country (2017-2028) & (K Units)
Table 33. North America Anti-Obesity Prescription Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Anti-Obesity Prescription Drugs Sales in Volume by Region (2017-2028) & (K Units)
Table 35. Asia Pacific Anti-Obesity Prescription Drugs Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Anti-Obesity Prescription Drugs Sales in Volume by Country (2017-2028) & (K Units)
Table 37. Europe Anti-Obesity Prescription Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Anti-Obesity Prescription Drugs Sales in Volume by Country (2017-2028) & (K Units)
Table 39. Latin Americaa Anti-Obesity Prescription Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Anti-Obesity Prescription Drugs Sales in Volume by Country (2017-2028) & (K Units)
Table 41. Middle East and Africa Anti-Obesity Prescription Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. F Hoffmann La Roche Ltd Corporation Information
Table 43. F Hoffmann La Roche Ltd Description and Business Overview
Table 44. F Hoffmann La Roche Ltd Anti-Obesity Prescription Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 45. F Hoffmann La Roche Ltd Anti-Obesity Prescription Drugs Product
Table 46. F Hoffmann La Roche Ltd Recent Development
Table 47. Orexigen Therapeutics Corporation Information
Table 48. Orexigen Therapeutics Description and Business Overview
Table 49. Orexigen Therapeutics Anti-Obesity Prescription Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 50. Orexigen Therapeutics Product
Table 51. Orexigen Therapeutics Recent Development
Table 52. Novo Nordisk A/s Corporation Information
Table 53. Novo Nordisk A/s Description and Business Overview
Table 54. Novo Nordisk A/s Anti-Obesity Prescription Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 55. Novo Nordisk A/s Product
Table 56. Novo Nordisk A/s Recent Development
Table 57. Arena Pharmaceuticals Corporation Information
Table 58. Arena Pharmaceuticals Description and Business Overview
Table 59. Arena Pharmaceuticals Anti-Obesity Prescription Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 60. Arena Pharmaceuticals Product
Table 61. Arena Pharmaceuticals Recent Development
Table 62. Glaxosmithkline Corporation Information
Table 63. Glaxosmithkline Description and Business Overview
Table 64. Glaxosmithkline Anti-Obesity Prescription Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 65. Glaxosmithkline Product
Table 66. Glaxosmithkline Recent Development
Table 67. Vivus Corporation Information
Table 68. Vivus Description and Business Overview
Table 69. Vivus Anti-Obesity Prescription Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 70. Vivus Product
Table 71. Vivus Recent Development
Table 72. Boehringer Ingelheim Corporation Information
Table 73. Boehringer Ingelheim Description and Business Overview
Table 74. Boehringer Ingelheim Anti-Obesity Prescription Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 75. Boehringer Ingelheim Product
Table 76. Boehringer Ingelheim Recent Development
Table 77. Alizyme Corporation Information
Table 78. Alizyme Description and Business Overview
Table 79. Alizyme Anti-Obesity Prescription Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 80. Alizyme Product
Table 81. Alizyme Recent Development
Table 82. Key Raw Materials Lists
Table 83. Raw Materials Key Suppliers Lists
Table 84. Anti-Obesity Prescription Drugs Customers List
Table 85. Anti-Obesity Prescription Drugs Distributors List
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-Obesity Prescription Drugs Product Picture
Figure 2. Global Anti-Obesity Prescription Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Anti-Obesity Prescription Drugs Market Size 2017-2028 (US$ Million)
Figure 4. Global Anti-Obesity Prescription Drugs Sales 2017-2028 (K Units)
Figure 5. United States Anti-Obesity Prescription Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Anti-Obesity Prescription Drugs Market Size 2017-2028 (US$ Million)
Figure 7. United States Anti-Obesity Prescription Drugs Sales 2017-2028 (K Units)
Figure 8. United States Anti-Obesity Prescription Drugs Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Anti-Obesity Prescription Drugs Market Share in Global, in Volume (K Units) 2017-2028
Figure 10. Anti-Obesity Prescription Drugs Report Years Considered
Figure 11. Product Picture of Pediatric
Figure 12. Product Picture of Adult
Figure 13. Global Anti-Obesity Prescription Drugs Market Share by Type in 2022 & 2028
Figure 14. Global Anti-Obesity Prescription Drugs Sales in Value by Type (2017-2028) & (US$ Million)
Figure 15. Global Anti-Obesity Prescription Drugs Sales Market Share in Value by Type (2017-2028)
Figure 16. Global Anti-Obesity Prescription Drugs Sales by Type (2017-2028) & (K Units)
Figure 17. Global Anti-Obesity Prescription Drugs Sales Market Share in Volume by Type (2017-2028)
Figure 18. Global Anti-Obesity Prescription Drugs Price by Type (2017-2028) & (US$/Unit)
Figure 19. United States Anti-Obesity Prescription Drugs Market Share by Type in 2022 & 2028
Figure 20. United States Anti-Obesity Prescription Drugs Sales in Value by Type (2017-2028) & (US$ Million)
Figure 21. United States Anti-Obesity Prescription Drugs Sales Market Share in Value by Type (2017-2028)
Figure 22. United States Anti-Obesity Prescription Drugs Sales by Type (2017-2028) & (K Units)
Figure 23. United States Anti-Obesity Prescription Drugs Sales Market Share in Volume by Type (2017-2028)
Figure 24. United States Anti-Obesity Prescription Drugs Price by Type (2017-2028) & (US$/Unit)
Figure 25. Product Picture of Hospitals Pharmacies
Figure 26. Product Picture of Retail Pharmacies
Figure 27. Product Picture of E-commerce
Figure 28. Global Anti-Obesity Prescription Drugs Market Share by Application in 2022 & 2028
Figure 29. Global Anti-Obesity Prescription Drugs Sales in Value by Application (2017-2028) & (US$ Million)
Figure 30. Global Anti-Obesity Prescription Drugs Sales Market Share in Value by Application (2017-2028)
Figure 31. Global Anti-Obesity Prescription Drugs Sales by Application (2017-2028) & (K Units)
Figure 32. Global Anti-Obesity Prescription Drugs Sales Market Share in Volume by Application (2017-2028)
Figure 33. Global Anti-Obesity Prescription Drugs Price by Application (2017-2028) & (US$/Unit)
Figure 34. United States Anti-Obesity Prescription Drugs Market Share by Application in 2022 & 2028
Figure 35. United States Anti-Obesity Prescription Drugs Sales in Value by Application (2017-2028) & (US$ Million)
Figure 36. United States Anti-Obesity Prescription Drugs Sales Market Share in Value by Application (2017-2028)
Figure 37. United States Anti-Obesity Prescription Drugs Sales by Application (2017-2028) & (K Units)
Figure 38. United States Anti-Obesity Prescription Drugs Sales Market Share in Volume by Application (2017-2028)
Figure 39. United States Anti-Obesity Prescription Drugs Price by Application (2017-2028) & (US$/Unit)
Figure 40. North America Anti-Obesity Prescription Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 41. North America Anti-Obesity Prescription Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 42. U.S. Anti-Obesity Prescription Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 43. Canada Anti-Obesity Prescription Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 44. Europe Anti-Obesity Prescription Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 45. Europe Anti-Obesity Prescription Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 46. Germany Anti-Obesity Prescription Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 47. France Anti-Obesity Prescription Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. U.K. Anti-Obesity Prescription Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. Italy Anti-Obesity Prescription Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. Russia Anti-Obesity Prescription Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Asia-Pacific Anti-Obesity Prescription Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 52. Asia-Pacific Anti-Obesity Prescription Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 53. China Anti-Obesity Prescription Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 54. Japan Anti-Obesity Prescription Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. South Korea Anti-Obesity Prescription Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. India Anti-Obesity Prescription Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. Australia Anti-Obesity Prescription Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. Taiwan Anti-Obesity Prescription Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Indonesia Anti-Obesity Prescription Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Thailand Anti-Obesity Prescription Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Malaysia Anti-Obesity Prescription Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Philippines Anti-Obesity Prescription Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Latin America Anti-Obesity Prescription Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 64. Latin America Anti-Obesity Prescription Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 65. Mexico Anti-Obesity Prescription Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 66. Brazil Anti-Obesity Prescription Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Argentina Anti-Obesity Prescription Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Middle East & Africa Anti-Obesity Prescription Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 69. Middle East & Africa Anti-Obesity Prescription Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 70. Turkey Anti-Obesity Prescription Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 71. Saudi Arabia Anti-Obesity Prescription Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. U.A.E Anti-Obesity Prescription Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. Anti-Obesity Prescription Drugs Value Chain
Figure 74. Anti-Obesity Prescription Drugs Production Process
Figure 75. Channels of Distribution
Figure 76. Distributors Profiles
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed
Industry Market Size
